Authors


Cynthia Toussaint

Latest:

It's Time to Put a Stop to Step Therapy

A guest editorial by Cynthia Toussaint. "If the Affordable Care Act survives the impending legal challenges and is fully implemented, it will eliminate a major barrier to health care by increasing access to care for millions of Americans suffering with chronic pain."


Patrick Campbell & Kevin Kunzmann

Latest:

Diabetes Amputation Risk Not Worsened by SGLT-2 Inhibitors

A 3 million-plus patient longitudinal study found the drug class was no worse for amputation risks than other diabetes therapies, despite recent conflicting studies.





Diana Fancher, DNP, MBA, RN

Latest:

Consolidation in the Hospital Industry

A look at the complex future of the hospital industry.





Juha Hartikainen, MD, PhD1: From the 1Departments of Surgery

Latest:

Can corticosteroids prevent atrial fibrillation after cardiac surgery?

We conducted a prospective, double-blind, randomized, multicenter study among 241 patients who underwent their first on-pump coronary artery bypass graft (CABG) surgery, aortic valve replacement (AVR), or combined CABG and AVR surgery to determine whether the use of hydrocortisone prevents atrial fibrillation after cardiac surgery. Results showed that the incidence of postoperative atrial fibrillation was significantly lower in the hydrocortisone group compared with the placebo group.


Robert Clarke, MD, FRCP: From the Clinical Trial Service Unit

Latest:

Cholesterol fractions and heart disease mortality in older men

The importance of blood lipids in the risk of ischemic heart disease in older people is unclear; as a result, cholesterol-lowering drug therapy is not widely prescribed for older individuals without diagnosed cardiovascular disease. We conducted a study to determine the relationship between death from ischemic heart disease and the level of cholesterol, cholesterol fractions, and apolipoproteins





Steven Borzak, MD is in private practice with Florida Cardiovascular Research, Atlantis, Florida.

Latest:

Sudden death after myocardial infarction

Anderson and Solomon (page 17) elegantly elucidate the patterns of sudden death after myocardial infarction (MI) in their analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT) database.



Jill Stein

Latest:

The Insidious Course of Hand Osteoarthritis

Treat the Pain & Functional Limitation



Thomas Schultz, DO

Latest:

Unusual appearance of a left ventricular mural thrombus

Postpartum cardiomyopathy is a serious disorder that can present from the third trimester to up to 5 months after pregnancy. Although spontaneous resolution of cardiac function occurs in more than half of patients (over a period of 6-12 months), the balance is left with persistent cardiac dysfunction. Cardiac dysfunction results in signs and symptoms of left heart failure, formation of apical or left ventricular thrombi, and arrhythmias and requires management similar to that in patients with nonischemic dilated cardiomyopathy.



Dr. Jan Gurley

Latest:

Healthcare Consummated...

We met cute. Classic Hollywood. America caught a glimpse of healthcare reform about a year ago--but only in passing, a little flirtatious hair-toss. Couldn't really see anything, veiled and shadowy, but God did she look great.





Q&A by Shivani Parmar, MPH

Latest:

Teaming Up for Better Health

Relationships are the foundation of any strong hospital medicine program. For 30 years, TeamHealth has been helping to build innovative hospital communities through its clinical outsourcing services and other solutions, all while focusing on a patient-centric, collaborative model of healthcare delivery.





Michael E. Schatman, PhD, CPE

Latest:

Anticonvulsants for Analgesia

This month, we will consider what is probably an underutilized class of medications – anticonvulsants – in treating many types of chronic pain syndromes.


Emily Chen, MD

Latest:

Low Likelihood of Adverse Cardiovascular Events Seen in Today's Survivors of Kawasaki Disease

Though it once led to major adverse cardiovascular events, Kawasaki disease has evolved into a condition that is routinely overcome without significant morbidity.

© 2024 MJH Life Sciences

All rights reserved.